International Archives of Medical Microbiology Int Arch Med Microbiol 10.23937/2643-4008 2643-4008 ClinMed International Library Wilmington, USA 10.23937 Streptococcus Agalactiae: An Unusual Agent of Inguinal Abscess Kaya A 10.23937/2643-4008/1710010 45-year-old man was admitted our clinic with complaint of low-grade fever and right inguinal mass and fatigue for ten days. On admission, body temperature was 37.5 ℃ and pulse was 90/min, this mass was swollen, painful and erythematous and tender to palpation. It was fluctuating. In the medical history, the patient has been alcoholic for 20 years. Clinical Image 2 1 OPEN ACCESS 10.23937/2643-4008/1710010 Streptococcus Agalactiae: An Unusual Agent of Inguinal Abscess Abdurrahman Kaya Department of Emergency, ASST Monza, Italy Mehtap Turfan Department of Emergency, ASST Monza, Italy Acar Yurtbasi Nuran Department of Emergency, ASST Monza, Italy Ekrem Sezgin Department of Emergency, ASST Monza, Italy Sibel Yildiz Kaya Department of Emergency, ASST Monza, Italy Abdurrahman Kaya
Specialist, MD, Department of Infectious Disease, İstanbul Training and Research Hospital, Istanbul, Turkey, Tel: +90-506-6113328
17 October 2019 Kaya A 2019 Streptococcus Agalactiae: An Unusual Agent of Inguinal Abscess Int Arch Med Microbiol 10.23937/2643-4148/1710013 2019 Kaya A © This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Streptococcus agalactiae (group B streptococcus; GBS) is gram-positive bacterium frequently colonized in pharynx, gastrointestinal and female genital tract. While the microorganism is also responsible for a wide range of infections which include sepsis and meningitis in newborn and chorioamnionitis and urinary tract infection in pregnant women, the incidence of invasive GBS disease has appeared to increase among non-pregnant adults and those with significant underlying conditions in the recent years. The infections of patient with medical illness are a common encountering problem in clinical practice. Individuals with significant medical condition have been increased all over the world. GBS-associated disease should be included in the early differential diagnosis in these patients and particularly inguinal abscesses.

Streptococcus agalactiae, Inguinal abscess, Mass

Streptococcus agalactiae (group B streptococcus; GBS) is gram-positive, β-hemolytic microorganism frequently colonized in pharynx, gastrointestinal and female genital tract [1,2]. The microorganism is also responsible for a wide range of infections which include sepsis and meningitis in newborn and chorioamnionitis and urinary tract infection in pregnant women [3]. These infections cause severe morbidity and mortality in these populations [4]. With prenatal screening and chemoprophylaxis, the diseases caused by the pathogen have dramatically decreased. However, the incidence of invasive GBS disease has appeared to increase among non-pregnant adults and those with significant underlying conditions in the recent years [1,5]. Here, we report an unusual presentation of this bacterium.

45-year-old man was admitted our clinic with complaint of low-grade fever and right inguinal mass and fatigue for ten days. On admission, body temperature was 37.5 ℃ and pulse was 90/min, this mass was swollen, painful and erythematous and tender to palpation. It was fluctuating. In the medical history, the patient has been alcoholic for 20 years. Laboratory tests were as follows: leukocyte 13000/mm3 (with neutrophilia predominance; 90%), C-reactive protein 20 mg/L (N: 0-5). Screening for HIV and syphilis were negative.

Ultrasound revealed a localized collection of purulent fluid with septations measuring 35 × 14 mm in size and that was consistent with an abscess formation (Figure 1). In the inguinal region, several reactive lymphadenopathies measuring 18 × 7 mm were seen. Subsequently, this collection was drained and cultured. In the gram stain of the aspirated sample, plenty of polymorphonuclear leukocytes and gram-positive bacteria were seen. Cefazolin 3 gr/day was immediately initiated empirically. Streptococcus agalactiae isolates were isolated from the solid and liquid medium culture of the samples. The antibiotic therapy switched to amoxicillin/clavulanate after 3 days of parenteral treatment. He was improved and then the swelling and erythema regressed within one week. The abnormal biochemistry returned to normal ranges. The therapy was continued up to two weeks. On follow-ups, the patient is doing well and with no recurrence.

Ingunial abscess with septations on ultrasound. https://www.clinmedjournals.org/articles/iamm/iamm-2-010-001.jpg

Streptococcus agalactiae is a very rare cause of infection in humans, other than newborn and pregnant women. A wide range of diseases including diabetes mellitus, malignancy, AIDS, hepatic and renal disease have been recognized as frequent predisposing factors for invasive GBS [6]. According to some studies, alcoholism is another risk factor for these bacterial infections [7]. While GBS-associated skin and soft tissue infections are one of the most common syndromes, inguinal abscess is very rarely reported clinical presentation [6]. As in this case, appropriate antimicrobial therapy combined with surgical intervention is essential for successful management in some cases.

As a conclusion, the infections of patient with medical illness are a common encountering problem in clinical practice. As a result of technological developments in modern treatment approaches, individuals with significant medical condition have been increased all over the world, GBS-associated disease should be included in the early differential diagnosis in these patients and particularly inguinal abscesses.

None.

References Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Eng J Med 342: 15-20.https://www.ncbi.nlm.nih.gov/pubmed/10620644 Zangwill KM, Schuchat A, Wenger JD (1992) Group B streptococcal disease in the United States, 1990: Report from a multistate active surveillance system. MMWR CDC Surveill Summ 41: 25-32.https://www.ncbi.nlm.nih.gov/pubmed/1470102 Wessels MR, Kasper KL (1993) The changing spectrum of group B Streptococcal disease. N Eng J Med 328: 1843-1844.https://www.ncbi.nlm.nih.gov/pubmed/8502275 Krohn MA, Hillier SL, Baker CJ (1999) Maternal peripartum complications associated with vaginal Group B Streptococci colonization. J Infect Dis 179: 1410-1415.https://academic.oup.com/jid/article/179/6/1410/961962 Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, et al. (2008) Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299: 2056-2065.https://www.ncbi.nlm.nih.gov/pubmed/18460666 Farley MM (2001) Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33: 556-561.https://www.ncbi.nlm.nih.gov/pubmed/11462195 Perovic O, Crewe-Brown HH, Khoosal M, Karstaedt AS (1999) Invasive group B streptococcal disease in nonpregnant adults. Eur J Clin Microbiol Infect Dis 18: 362-364.